Related Experiment Video
Updated: May 26, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Exploring the link between atherosclerosis indicators and QT interval in type 2 diabetes: a retrospective
Shunsuke Kobayashi1, Mototsugu Nagao1, Izumi Fukuda2
1Department of Endocrinology, Metabolism and Nephrology, Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan.
Insights
Vascular endothelial dysfunction (FMD) is linked to prolonged QT intervals in type 2 diabetes patients, especially those who are not obese. This finding aids in identifying individuals at higher risk for dangerous heart arrhythmias.
Area of Science:
- Cardiology
- Endocrinology
- Vascular Medicine
Background:
- Prolonged QT interval is a risk factor for life-threatening arrhythmias and sudden cardiac death.
- Identifying clinical markers for myocardial repolarization abnormalities is crucial for risk stratification in type 2 diabetes patients.
Purpose of the Study:
- To investigate the association between non-invasive atherosclerosis indicators and corrected QT (QTc) interval prolongation.
- To assess the relationship between QTc interval and markers of vascular health in type 2 diabetes.
Main Methods:
- Retrospective cross-sectional analysis of 96 type 2 diabetes patients.
- QTc interval calculated using Bazett, Fridericia, and Framingham formulas.
- Assessment of ankle-brachial index (ABI), cardio-ankle vascular index (CAVI), carotid intima-media thickness (IMT), and flow-mediated dilatation (FMD).
Main Results:
- Flow-mediated dilatation (FMD) was negatively correlated with QTcB in univariate analyses (r = -0.28, p = 0.0054).
- FMD was independently associated with QTcB in multivariable analyses (β = -1.95 ms per 1% increase; p = 0.021).
- The association between FMD and QTc prolongation was more prominent in non-obese patients (BMI < 25 kg/m²).
Conclusions:
- Vascular endothelial dysfunction, indicated by FMD, is independently associated with QTc prolongation in type 2 diabetes.
- This association is particularly significant in non-obese individuals, suggesting a link to increased arrhythmia risk.
- Findings highlight FMD as a potential marker for identifying high-risk patients with type 2 diabetes.
Background:
A prolonged QT interval is a recognized risk factor for life-threatening arrhythmias and sudden cardiac death. In patients with type 2 diabetes, identifying clinical markers associated with myocardial repolarization abnormalities is essential for risk stratification.
Objectives:
To investigate the association between multiple non-invasive atherosclerosis indicators and corrected QT interval prolongation in patients with type 2 diabetes.
Design:
Retrospective cross-sectional analysis.
Methods:
We evaluated 96 patients with type 2 diabetes admitted for glycemic control. The QTc interval was calculated using the Bazett (QTcB), Fridericia (QTcF), and Framingham (QTcFra) formulas. We examined the association between QTc and multiple atherosclerosis indicators, including the ankle-brachial index (ABI), cardio-ankle vascular index (CAVI), carotid intima-media thickness (IMT), and flow-mediated dilatation (FMD).
Results:
Among all participants, 2 women (7%) and 10 men (15%) had prolonged QTcB. In univariate analyses, FMD was negatively correlated with QTcB (r = -0.28, p = 0.0054), whereas ABI, CAVI, mean, and maximum carotid IMT did not exhibit significant associations. In multivariable linear regression analyses, FMD was independently associated with QTcB (unstandardized coefficient β = -1.95 ms per 1% increase in FMD; 95% confidence interval -3.60 to -0.30; p = 0.021). Subgroup analysis revealed that this association was prominent specifically in the non-obese group (body mass index, <25 kg/m²). Notably, these findings remained consistent regardless of the correction formula used.
Conclusion:
Vascular endothelial dysfunction, as measured by FMD, is independently associated with QTc prolongation, particularly in non-obese patients with type 2 diabetes. This suggests a significant link that may help identify individuals at higher risk for life-threatening arrhythmias.
Related Concept Videos
Coronary Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
